Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koenig, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenig, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1039-1041
© 2003 European Renal Association-European Dialysis and Transplant Association


Editorial Comment

C-reactive protein and cardiovascular risk: an update on what is going on in cardiology

Wolfgang Koenig

Department of Internal Medicine II, Cardiology, University of Ulm Medical Center, Ulm, Germany

Keywords: C-reactive protein; cardiovascular risk; clinical relevance; mechanisms

The first 150 words of the full text of this article appear below.

C-reactive protein and cardiovascular risk prediction: what is already known

The role of elevated high-sensitivity (hs) C-reactive protein (CRP) as a risk marker for cardiovascular (CV) diseases, including coronary heart disease (CHD) [1], stroke [2] and peripheral arterial disease [3] is well established through consistent results from a number of prospective studies. But CRP also conveys important prognostic information in the setting of the acute coronary syndrome. Subjects presenting with unstable angina or non ST-elevation myocardial infarction (MI) and increased levels of hs-CRP are candidates for a variety of adverse events like recurrent angina, ST elevation MI or coronary death. This holds true short-term for in-hospital complications but also long-term over years as has recently convincingly been shown by data from the FRISC trial [4]. Even in the presence of the results of troponin measurements, hs-CRP adds relevant prognostic information [5]. Moreover, persistent elevation of hs-CRP levels after optimal treatment . . . [Full Text of this Article]

New findings in primary prevention

New associations with CRP relevant to cardiology

New-onset type 2 diabetes
The insulin resistance syndrome
Renal insufficiency
Obstructive sleep apnea
Persistent atrial fibrillation
Air pollution
CRP: risk marker or risk factor?

Conclusions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Psychosom. Med.Home page
E. C. Suarez
C-Reactive Protein Is Associated With Psychological Risk Factors of Cardiovascular Disease in Apparently Healthy Adults
Psychosom Med, September 1, 2004; 66(5): 684 - 691.
[Abstract] [Full Text] [PDF]